JP2024529960A5 - - Google Patents
Info
- Publication number
- JP2024529960A5 JP2024529960A5 JP2024504817A JP2024504817A JP2024529960A5 JP 2024529960 A5 JP2024529960 A5 JP 2024529960A5 JP 2024504817 A JP2024504817 A JP 2024504817A JP 2024504817 A JP2024504817 A JP 2024504817A JP 2024529960 A5 JP2024529960 A5 JP 2024529960A5
- Authority
- JP
- Japan
- Prior art keywords
- drug conjugate
- valine
- pharmaceutical composition
- influenza
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163226713P | 2021-07-28 | 2021-07-28 | |
| US63/226,713 | 2021-07-28 | ||
| PCT/US2022/038723 WO2023009754A2 (en) | 2021-07-28 | 2022-07-28 | Protein-antiviral compound conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529960A JP2024529960A (ja) | 2024-08-14 |
| JP2024529960A5 true JP2024529960A5 (https=) | 2025-10-16 |
Family
ID=83115616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024504817A Pending JP2024529960A (ja) | 2021-07-28 | 2022-07-28 | タンパク質－抗ウイルス化合物コンジュゲート |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250041433A1 (https=) |
| EP (1) | EP4376895A2 (https=) |
| JP (1) | JP2024529960A (https=) |
| KR (1) | KR20240038928A (https=) |
| CN (1) | CN117813119A (https=) |
| AU (1) | AU2022320713A1 (https=) |
| CA (1) | CA3220081A1 (https=) |
| IL (1) | IL307947A (https=) |
| MX (1) | MX2024000897A (https=) |
| WO (1) | WO2023009754A2 (https=) |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4393937A (en) | 1981-03-25 | 1983-07-19 | Shell Oil Company | Olefin sulfonate-improved steam foam drive |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| US5714586A (en) | 1995-06-07 | 1998-02-03 | American Cyanamid Company | Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US20070258987A1 (en) | 2000-11-28 | 2007-11-08 | Seattle Genetics, Inc. | Recombinant Anti-Cd30 Antibodies and Uses Thereof |
| AR048098A1 (es) | 2004-03-15 | 2006-03-29 | Wyeth Corp | Conjugados de caliqueamicina |
| US7750116B1 (en) | 2006-02-18 | 2010-07-06 | Seattle Genetics, Inc. | Antibody drug conjugate metabolites |
| WO2008122039A2 (en) | 2007-04-02 | 2008-10-09 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Selenocysteine mediated hybrid antibody molecules |
| EP2167963B1 (en) | 2007-05-23 | 2019-04-17 | Ventana Medical Systems, Inc. | Polymeric carriers for immunohistochemistry and in situ hybridization |
| SG189817A1 (en) | 2008-04-30 | 2013-05-31 | Immunogen Inc | Potent conjugates and hydrophilic linkers |
| SI2528625T1 (sl) | 2010-04-15 | 2013-11-29 | Spirogen Sarl | Pirolobenzodiazepini in njihovi konjugati |
| US20130244905A1 (en) | 2010-07-06 | 2013-09-19 | Ed Grabczyk | Reporter for RNA Polymerase II Termination |
| CA2813411C (en) | 2010-11-05 | 2016-08-02 | Rinat Neuroscience Corporation | Engineered polypeptide conjugates and methods for making thereof using transglutaminase |
| CN110078789A (zh) | 2011-05-27 | 2019-08-02 | Ambrx 公司 | 含有非天然氨基酸连接的海兔毒素衍生物的组合物、涉及该海兔毒素衍生物的方法及其用途 |
| US8815226B2 (en) | 2011-06-10 | 2014-08-26 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| CN103997893B (zh) | 2011-10-14 | 2019-04-12 | 西雅图基因公司 | 吡咯并苯并二氮杂卓和靶向结合物 |
| EP2751111B1 (en) | 2011-10-14 | 2017-04-26 | MedImmune Limited | Asymmetrical bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one) derivatives for the treatment of proliferative or autoimmune diseases |
| CA2850373C (en) | 2011-10-14 | 2019-07-16 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| BR112014009070B1 (pt) | 2011-10-14 | 2021-11-23 | Medimmune Limited | Método de síntese e intermediários úteis na preparação de pirrolobenzo-diazepinas |
| WO2013068874A1 (en) | 2011-11-11 | 2013-05-16 | Pfizer Inc. | Antibody-drug conjugates |
| CN105142672B (zh) | 2012-10-23 | 2019-04-05 | 西纳福克斯股份有限公司 | 经修饰的抗体、抗体-缀合物及其制备方法 |
| TWI702229B (zh) | 2014-12-19 | 2020-08-21 | 美商再生元醫藥公司 | 流行性感冒病毒血球凝集素之人類抗體 |
| US20210393786A1 (en) * | 2018-07-26 | 2021-12-23 | Purdue Research Foundation | Small molecule ligand-targeted drug conjugates for anti-influenza chemotherapy and immunotherapy |
| JP2023511956A (ja) * | 2020-01-24 | 2023-03-23 | レゲネロン ファーマシューティカルス，インコーポレーテッド | タンパク質－抗ウイルス化合物コンジュゲート |
-
2022
- 2022-07-28 CA CA3220081A patent/CA3220081A1/en active Pending
- 2022-07-28 US US18/580,547 patent/US20250041433A1/en active Pending
- 2022-07-28 WO PCT/US2022/038723 patent/WO2023009754A2/en not_active Ceased
- 2022-07-28 IL IL307947A patent/IL307947A/en unknown
- 2022-07-28 MX MX2024000897A patent/MX2024000897A/es unknown
- 2022-07-28 CN CN202280051229.0A patent/CN117813119A/zh active Pending
- 2022-07-28 EP EP22761315.5A patent/EP4376895A2/en active Pending
- 2022-07-28 AU AU2022320713A patent/AU2022320713A1/en active Pending
- 2022-07-28 KR KR1020237044149A patent/KR20240038928A/ko active Pending
- 2022-07-28 JP JP2024504817A patent/JP2024529960A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7520816B2 (ja) | ウイルス感染症の治療のための組成物及び方法 | |
| JP2017537893A5 (https=) | ||
| US20140199299A1 (en) | Combination Therapies and Methods Using Anti-CD3 Modulating Agents and Anti-IL-6 Antagonists | |
| JP2023538369A5 (https=) | ||
| JP2021527640A5 (https=) | ||
| JP2021528423A5 (https=) | ||
| JP2023055904A5 (https=) | ||
| JP2025183307A5 (https=) | ||
| JP2024531151A5 (https=) | ||
| WO2022199237A1 (zh) | 修饰的氨基酸及其在adc中的应用 | |
| JP2023511956A5 (https=) | ||
| JP2025148380A5 (https=) | ||
| NZ725965A (en) | Method for biocatalytic whole cell reduction of dehydrocholic acid compounds, and 7-beta-hydroxysteroid dehydrogenase mutants | |
| EP2224943A1 (en) | Use of human antibody capable of neutralizing hepatitis b virus for the prevention or treatment of hepatitis b virus infection | |
| IL275884B1 (en) | Human antibodies to influenza hemagglutinin | |
| JP2021506817A5 (https=) | ||
| CA3168496A1 (en) | Protein-antiviral compound conjugates | |
| JP2024529960A5 (https=) | ||
| JP2023502398A5 (https=) | ||
| JP2021533142A5 (https=) | ||
| CN116669761A (zh) | 一种t细胞衔接器治疗剂的开发和应用 | |
| JP2023506779A5 (https=) | ||
| JP2022553703A5 (https=) | ||
| RU2024114721A (ru) | Композиции на основе антител к тау-белку, их лекарственные формы и способы их применения | |
| JP2024529960A (ja) | タンパク質－抗ウイルス化合物コンジュゲート |